Literature DB >> 1978741

Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus.

J J Wagner1, R M Caudle, J F Neumaier, C Chavkin.   

Abstract

Physiological release of endogenous opioids in the rat hippocampus was detected by an in vitro radioligand displacement assay using [3H][D-Ala2,N-methyl-Phe4,glyol5]enkephalin ([3H]DAGO), a mu selective opioid agonist. In this assay, radioligand binding to opioid receptors in the in vitro hippocampal slice was reduced by competition with endogenous opioids released following tissue depolarization. Veratridine-induced opioid release caused displacement of [3H]DAGO that could be blocked by either tetrodotoxin addition or calcium removal from the incubation buffer. Maximal displacement of [3H]DAGO also required the presence of peptidase inhibitors in the incubation buffer. None of the buffer composition changes directly affected [3H]DAGO binding to rat brain membranes. Calcium-dependent displacement of [3H]DAGO binding from mu receptor sites elicited by focal electrical stimulation depended on the intensity and frequency of stimulation and positioning of the electrode in the slice. Maximal displacement of [3H]DAGO binding was observed following high intensity (150-300 microA), high frequency (10-50 Hz) stimulation of the perforant path, a major afferent fiber system to the hippocampus previously shown to contain proenkephalin-derived opioids. Low frequency stimulation (0.1-1 Hz) was ineffective. Stimulation of the mossy fibers (containing both dynorphins and enkephalins) also significantly reduced mu receptor binding, but to a lesser extent. Electrical stimulation of the hippocampal slice at sites not containing opioid peptides did not cause mu receptor displacement. These results demonstrate that under physiological conditions, the release of endogenous opioids from the major opioid containing pathways can be detected in a single hippocampal slice following high frequency stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978741     DOI: 10.1016/0306-4522(90)90190-f

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Actions of endogenous opioids on NMDA receptor-independent long-term potentiation in area CA3 of the hippocampus.

Authors:  S H Williams; D Johnston
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

2.  Mu opioid receptor activation normalizes temporo-ammonic pathway driven inhibition in hippocampal CA1.

Authors:  A Rory McQuiston
Journal:  Neuropharmacology       Date:  2010-11-04       Impact factor: 5.250

3.  Endogenous opioid peptides contribute to associative LTP in the hippocampal CA3 region.

Authors:  Carlo O Martinez; Viet H Do; Brian E Derrick
Journal:  Neurobiol Learn Mem       Date:  2011-05-06       Impact factor: 2.877

4.  Hippocampal mossy fiber activity evokes Ca2+ release in CA3 pyramidal neurons via a metabotropic glutamate receptor pathway.

Authors:  A Kapur; M Yeckel; D Johnston
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  Focal stimulation of specific pathways in the rat hippocampus causes a reduction in radioligand binding to the haloperidol-sensitive sigma receptor.

Authors:  M A Connor; C Chavkin
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Frequency-dependent associative long-term potentiation at the hippocampal mossy fiber-CA3 synapse.

Authors:  B E Derrick; J L Martinez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

7.  Endogenous activation of mu and delta-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: dependence on GABAergic inhibition.

Authors:  C R Bramham; J M Sarvey
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

8.  Changes in hippocampal circuitry after pilocarpine-induced seizures as revealed by opioid receptor distribution and activation.

Authors:  S B Bausch; C Chavkin
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

9.  Evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the Rat.

Authors:  J L Henry; K Yashpal; G M Pitcher; J Chabot; T J Coderre
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

10.  Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors.

Authors:  A Torres-Reveron; S Khalid; T J Williams; E M Waters; L Jacome; V N Luine; C T Drake; B S McEwen; T A Milner
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.